{"id":"W4385334309","doi":"10.1200/jco.23.00775","title":"ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Obinutuzumab; Internal medicine; Neutropenia; Gastroenterology; Clinical endpoint; Rituximab; Phases of clinical research; Hazard ratio; Adverse effect; Surgery; Randomized controlled trial; Lymphoma; Chemotherapy; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001802797,0.001137716,0.001559087,0.0003580159,0.0002976723,0.0008834566,0.00100334,0.0009740917,0.006435315],"category_scores_gemma":[0.001170278,0.0005002875,0.001017064,0.0003449042,0.0008288863,0.0007681184,0.0004197629,0.0022616,0.0008584347],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006195758,"about_ca_system_score_gemma":0.0009168962,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000937944,"about_ca_topic_score_gemma":0.003002322,"domain_scores_codex":[0.9994204,0.000363299,0.00002375448,0.00007585762,0.00005147597,0.00006531694],"domain_scores_gemma":[0.9995004,0.0001146321,0.000128501,0.00004073692,0.00002929786,0.0001864284],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9397179,0.01120102,0.001629751,0.0007317531,0.001190551,0.00007720476,0.00009309679,0.0004792466,0.008759666,0.0001962335,0.00135861,0.03456501],"study_design_scores_gemma":[0.9272643,0.06775127,0.00248433,0.00002100977,0.0005489289,0.00005500285,0.00001794682,0.0003606716,0.0005157015,0.00006381532,0.0009063643,0.00001063411],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9876402,0.004163258,0.0005153396,0.0006588544,0.0001833741,0.003139541,0.0009088632,0.0001182617,0.002672247],"genre_scores_gemma":[0.9880021,0.002650206,0.001543824,0.000730936,0.0001845526,0.002514128,0.0009161978,0.00001962654,0.003438461],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006435315,"threshold_uncertainty_score":0.02152824,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1139835233524448,"score_gpt":0.4717419386539264,"score_spread":0.3577584153014816,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}